A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

NCT01149798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Abraxane and Cisplatin combination

Sponsor

Fudan University